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Abstract
Population structure can be a source of both false-positive and false-negative findings in a genome-wide association study.
This article proposes an approach that helps to reduce the false-positives. It consists of homogenizing the diseased/healthy
phenotype ratio across the cohort, by decreasing the statistical weight of selected individuals. After homogenization, the
cohort is statistically handled as if originating from a single well-mixed population. The method was applied to homogenize
a Parkinson’s disease genome-wide association study cohort.
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Introduction
The genome-wide association study (GWAS) is nowadays
routinely used to discover genetic susceptibilities to disease
[1,2,3]. In these studies, a critical step is the handling of
population structure in the analyzed cohort [4,5]. If not correctly
accounted for, population structure can result in both false-
positive and false-negative phenotype-genotype associations. We
briefly review some of the main approaches currently utilized to
identify and correct for the presence of population structure in a
cohort [6,7,8]. Genomic control is a computationally fast and
easy to implement method [9,10,11]. It prescribes a reduction by
a factor l in the cohort size utilized in test statistical calculations.
This compensates for statistical significance inflation due to the
presence of population structure. The method assumes that only
the few strongest statistical associations reflect genuine pheno-
type-genotype associations and thus it estimates the l factor
based on the remaining bulk of the test statistics distribution.
Dadd et al. [12] discuss refinements and variations on the
genomic control approach. An example is the use of multiple
rather than a single adjustment factor [13]. A different approach
is to first capture ancestry by changing the cohort data to the
principal component coordinates of a space defined by a set of
markers assumed to be independent of the trait under analysis
[14,15]. The first few principal components can then be utilized
as regression covariates in the subsequent association analysis
[16,17]. Other population structure correction approaches based
on the calculated principal components have also been proposed
[18,19,20,21]. As an alternative to principal component analysis,
population structure can also be captured by the multidimen-
sional-scaling (MDS) statistical technique [20,22,23]. Li et al.
[24], report a method that combines MDS with a phylogeny
constructed from SNP genotypes. Spectral graph theory provides
yet a different way to capture genetic ancestry. Two implemen-
tations of this approach are Spectral-GEM [25] and LAP-
STRUCT [26]. Structured association methods first assign to
individuals probabilities of membership in given subpopulations
[27,28]. Association testing is then conditional on these
subpopulation membership probabilities [29]. STRUCTURE/
STRAT [30] and ADMIXMAP [31] are standard software
packages that implement this method. Structured association
approaches tend to be computationally intensive, but the GWAS
analysis package Plink [32] includes a simplified, efficient version
of structured association. Finally, linear mixed models [33,34]
have been also successfully applied to address population
structure. Wu reports a performance comparison of some of
the above approaches [35].
To assist in reducing the specific case of false-positives, this
article suggests the additional avenue of homogenizing the ratio
between the two GWAS phenotypes (e.g., diseased and healthy)
throughout the cohort. The homogenization is performed
within a principal component coordinates space and is
accomplished by knocking-down the statistical weight of selected
individuals. After homogenization, the cohort is statistically
handled as if originating from a single well-mixed population.
First, under the idealization of exactly two distinct populations,
we recall the biases introduced by population structure in a
GWAS. We then present our homogenization approach for the
practical case where the cohort population structure has a
continuous character. The method is described alongside its
application to the homogenization of a Parkinson’s disease
GWAS cohort [36]. Finally, the method is tested using
simulated, synthetic data.
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Analysis
Two populations case
Consider a population of individuals classified into two
genotypes (A and ,A) and likewise classified into two phenotypes
(diseased and healthy). The genotype-phenotype population odds
ratio (OR) [37] quantifies the degree of correlation between
genotype and phenotype intrinsic to the population. A cohort
sampled from the population provides an estimate of the OR. One
of the four degrees of freedom (DOFs) of the sampled cohort’s 262
contingency table (Figure 1-a) can thus be assigned to the OR
estimate. Call it the OR DOF. The remaining three DOFs then
reflect how the cohort was sampled from the population. These
three sampling DOFs may be expressed as:
p1 - number of patients sampled,
p2 - number of healthy subjects sampled and
p3 - sampling partiality towards A subjects versus towards ,A
subjects.
Any selection for the three sampling DOFs is valid, as they are
independent of the OR DOF. Still, correctness of the OR estimate
requires every patient and healthy subject to be sampled under the
same partiality value p3. However, population differences in the
relative prevalence of A and ,A subjects are conducive to
different p3 sampling partialities. Therefore casually combining
samples from different populations is problematic, as illustrated by
the following two examples. Consider two populations X and Y,
where in both the OR is unity (Figure 1-b). Let population X have
a preponderance of genotype A and population Y have a
preponderance of genotype ,A, thus inducing different sampling
partialities p3. Additionally, regarding DOFs p1 and p2, suppose in
population X mostly patients were sampled (i.e., p1 .. p2) while
in population Y mostly healthy controls were sampled (i.e., p1 ,,
p2). Then, combining the samples from X and Y in a single cohort
results in a non-unity OR estimate, a false-positive genotype-
phenotype correlation due population structure. As a second
example, consider two populations X and Y, where in both the
OR<2 (Figure 1-c). As in the previous example, suppose p3 is
much larger in X than in Y. Let the exact same number of
diseased and healthy subjects be sampled in X and in Y. Then,
combining the samples from X and Y in a single cohort results in
an OR estimate that is approximately unity, in spite of the OR in
both the X and Y populations being approximately 2. This second
example illustrates population structure concealing a genuine
genotype-phenotype correlation. For both examples, we empha-
size how the OR, and thus the genotype-phenotype correlation, is
identical in the X and Y populations. Population structure led to
the false-positive and false-negative calls solely by affecting
sampling.
Transformations can be applied to the contingency table.
Discarding diseased samples is akin to scaling by a less than unity
common factor the contingency table entries a and b (Figure 1-a).
Similarly, discarding healthy samples is akin to scaling by a less
than unity common factor the entries c and d. Equivalently, we
may always plausibly assume a cohort resulted from sampling a
selected number of A subjects and a selected number of ,A
subjects, all under a given sampling partiality between diseased
and healthy subjects. From this perspective, the three sampling
DOFs could be expressed as:
Figure 1. Odds ratio estimation biases introduced by popula-
tion structure. a) The 262 contingency table associated with a cohort
sampled from the population. Merging cohorts from distinct popula-
tions can produce both false-positive and false-negative assessments of
the odds ratio (OR). Differences in the sampling process invalidate a
straightforward combination of cohorts from distinct populations. b)
False-positive example: In both population X and population Y, the
OR= 1. c) False-negative example: In both population X and population
Y, the OR<2.
doi:10.1371/journal.pone.0048653.g001
Figure 2. Distribution of patients and controls in the original
cohort. The Hamza et al. [36] cohort healthy and Parkinson’s
individuals projected on the first 2 principal components of the SNP
space. The cohort contains a total of 2000 Parkinson’s patients and 1986
healthy controls.
doi:10.1371/journal.pone.0048653.g002
GWAS Cohort Homogenization
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g1 - number of A subjects sampled,
g2 - number of ,A subjects sampled and
g3 - sampling partiality towards diseased subjects versus towards
healthy subjects.
Now, discarding A samples is akin to scaling by a less than unity
common factor the entries a and c. Similarly, discarding healthy
samples is akin to scaling by a less than unity common factor the
entries b and d.
Let us call p3 matched cohorts to those cohorts that could plausibly
originate from a sampling of diseased and healthy subjects under
the same partiality p3. Similarly, let us call g3 matched cohorts to those
cohorts that could plausibly originate from a sampling of A and
,A subjects under the same partiality g3. Only p3 or g3 matched
cohorts are suitable to being merged. Fortunately, the above-
mentioned transformations can be utilized to produce matched
cohorts. For instance, the transformations can always be used to
equalize the corresponding marginal ratios in the two contingency
tables (i.e., making the net A/,A ratio equal on the two tables and
making the net diseased/healthy ratio equal on the two tables).
Doing so produces cohorts that are both p3 and g3 matched.
In a GWAS, there is typically a vast number of genotype based
population splits to consider and each requires its own cohort-
matching transformation. Furthermore, population structure
generally has a more complex continuous character than the
two distinct populations assumed so far. Thus, computational-time
wise cohort-matching for every genetic trait may not be feasible.
Instead, we suggest equalizing the net diseased/healthy subject
marginal ratio on the two cohorts. This can be achieved by
appropriately discarding diseased or healthy samples (without
regards to their genotype). Note that this equalization is
independent of the genotype split under consideration. Now, if
the OR is unity in the two populations, then the matching of the
diseased/healthy subject ratio guarantees that the cohorts are g3
matched. This follows from an unity OR indicating that the
diseased/healthy ratio in the population is identical for both
genotypes under consideration. Note that the method is robust: in
the limit where the individual population ORs approach unity and
the cohort marginal diseased/healthy ratios approach each other,
the cohorts approach being g3 matched. The limitation of the
approach is that, for non-unity ORs, matching the diseased/
healthy ratio no longer guarantees that the cohorts are g3 matched.
This is clear in the Figure 1-c example, where the diseased/healthy
ratio is unity in both cohorts and yet, the merged cohort produces
a false-negative outcome. A careful examination of the example
will show that the sampling is partial towards healthy subjects in
population X relative to the sampling in population Y. Let us call
phenotype marginal matching to this procedure of matching the
diseased/healthy ratios in the cohorts. In summary, phenotype
marginal matching reduces the false-positives (Figure 1-b case) but
not the false-negatives (Figure 1-c case). However, the computa-
tional faster time, due to a single homogenization serving for all
genotype pairs, makes it a practical choice. Finally, note that
throughout we have assumed that the OR is the same in both
populations. However, the OR could also be population depen-
dent. As an example, consider a SNP that is a risk factor only
under the net genetic background or dietary habits characteristic
of a particular population. Such cases always benefit from an
individualized analysis of the population cohorts, as their merging
unavoidably produces some form of averaged OR estimate.
A commonly applied test to the cohort contingency table is the
Fisher exact test [38]. Importantly, note that the test is valid on a
contingency table from merged cohorts that were phenotype
marginal matched, since the unity OR assumption of the test also
guarantees that the cohorts are g3 matched.
Continuous population structure case
So far we have assumed two well-defined, distinct populations.
We now describe our phenotype marginal matching approach for
the practical case where the population structure has a continuous
character. The method is presented alongside its application to
homogenization of the Hamza et al. Parkinson’s GWAS cohort
[36,39]. This cohort of 2000 Parkinson’s disease patients and 1986
controls was genotyped at on the order of 106 SNPs. Subjects were
recruited in North America and reported European ancestry. We
first identified the population structure as Hamza et al. [36], via
principal component analysis [16,36]. The relative overall location
of individuals in SNP space (Euclidean distance wise) reflects the
cohort population structure. However, there are regions of the
genome with a particular high density of genotyped, highly
correlated SNPs. This results in a few such groups of SNPs
overwhelmingly determining the clustering of subjects in SNP
space. Following standard procedure [36], this was avoided by
utilizing only a reduced set of 75 000 SNPs, selected for their
comparatively lower correlation. The SNPs were selected using the
program Plink [32], with a 50-SNP sliding window, shifting 5
SNPs with each move and recursively removing SNPs with
Figure 3. The population homogenization algorithm. a)
Euclidean-distance spheres on the space defined by the first three
principal component projections of the 75000 SNP space (3PC-space).
The spheres are characterized by the total subject statistical weight in
their interior, rather than by their spatial radius. The sphere OR is
defined as the OR for an idealized genotype present in every subject in
the interior of that sphere and in no subject outside of it. ORs are
estimated for all spheres centered on a cohort subject and of a
predefined sphere weight. b) Overview of the homogenization
algorithm. c) Within the sphere with the most extreme OR estimate,
one subject is selected to have its statistical weight knocked-down to a
predefined knocked-down weight.
doi:10.1371/journal.pone.0048653.g003
GWAS Cohort Homogenization
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r2.0.1. As discusssed in Hamza et al., the population structure is
well captured by the first three principal components of this 75 000
SNP space. In here, our objective is therefore to homogenize the
diseased/healthy subject ratio (phenotype marginal match)
throughout the subspace defined by these first three principal
components (henceforth 3PC-space). The uneven distribution of
healthy and Parkinson’s subjects in this space is visually perceptible
in Figure 2 (third principal component not shown).
The homogenization is performed by lowering the statistical
weight (‘statistical’ subsumed henceforth) of select subjects from
their original unity weight, to a smaller, but nonzero, predefined
knocked-down weight. Henceforth, let all spatial references be with
respect to 3PC-space and based on Euclidean distances. We define
the sphere OR as the OR for an idealized genotype present nowhere
other than on every subject within that spatial sphere (Figure 3-a).
Such a genotype thus marks exactly the population present within
the sphere. The homogenization algorithm will employ spheres
centered on cohort subjects. In lieu of sphere spatial radius, a more
relevant parameter is sphere cohort weight, the total weight of the
cohort subjects inside the sphere. This is due to the pertinent
statistical comparison, as described below, being between spheres
with the same cohort weight, not between spheres with the same
spatial size per se.
We now describe the iterative homogenization algorithm
(Figure 3-b,c). The sphere OR for every sphere with a
predetermined cohort weight and centered around a cohort
subject is estimated (note on weight discreteness: in practice, utilize
the smallest sphere centered on the subject that equals or surpasses
the desired weight). The sphere with the most extreme OR
estimate is selected (given the symmetry in the OR definition, by
extreme it is meant furthest from unity, in the sense whereby
OR=3 and OR=1/3 are equally distanced from unity). Next, the
weight of one cohort subject within this selected sphere is knocked-
down in order to bring the sphere estimated OR closer to unity.
The subject closest to the sphere center, still with unity weight and
of the appropriate phenotype (diseased if the OR imbalance is due
to too many diseased subjects within the sphere, healthy in the
reverse case) is selected to have its weight knocked-down to the
Figure 5. Statistically knocked-down individuals in the cohort
homogenization process. The local homogenization of the Parkin-
son’s/healthy marginal ratio (phenotype marginal matching) is per-
formed by knocking-down the statistical weight of selected subjects.
Overall, 120 of the 2000 Parkinson’s patients and 230 of the 1986
healthy controls had their statistical weight knocked-down from 1 to
0.2. This represented a 7% net weight decrease in the cohort.
doi:10.1371/journal.pone.0048653.g005
Figure 4. Algorithm parameter optimization. The algorithm was
applied to homogenize the Hamza et al. cohort. The algorithm
parameters were selected based on the value of the potential p-value
bias test (see Table 1 and main text). Graph a) shows potential p-value
bias versus % of cohort weight decrease. A 7% cohort weight decrease
was selected, as weight decreases beyond this value produced only a
marginal further decline in the potential p-value bias. b) The sphere
weight parameter was set to 30. c) A 0.2 knocked-down weight was
selected. In each of these graphs, the two parameters not represented
are held at their selected values.
doi:10.1371/journal.pone.0048653.g004
GWAS Cohort Homogenization
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predefined knocked-down weight. The cycle is then repeated, with
every sphere OR being re-calculated, a new sphere with the most
extreme OR being highlighted and, within it, a new subject being
selected for knock-down. This cycle is performed a determined
number of times (set by the desired final cohort weight) upon
which the procedure is concluded.
The algorithm requires selecting values for three parameters:
total cycles (or final decrease in cohort weight), sphere weight and
knocked-down weight (Figure 3). To select these, we introduce the
potential p-value bias test. This is a measure of the OR estimate Fisher
p-value bias potential due to population structure in the cohort.
Consider again a hypothetical genotype present on every
individual within a given spatial sphere and on none outside that
sphere. This constitutes an extreme case of a genotype associated
with a specific population (in this case, the population within the
sphere). This genotype produces a false-positive OR estimate if the
diseased/healthy ratio is not identical inside and outside the
sphere. The smallest p-value that can be generated by such
hypothetical genotypes thus provide a measure of the potential for
p-value bias introduced by population structure. We numerically
implement this test by considering all spheres centered on cohort
subjects, hence effectively covering every relevant sphere location
in 3PC-space. Similarly, a spectrum of sphere weights is
considered. The value of the potential p-value bias test is then
the smallest of the p-values thus generated.
The algorithm was applied to the Hamza et al. cohort. Based on
the potential p-value bias test, the parameters were set to cohort
weight decrease = 7%, sphere weight = 30 and knocked-down
weight = 0.2 (Figure 4). We underline the limited sensitivity of the
potential p-value bias test results to the selected parameter values,
indicating the algorithm is robust in this regard (Figure 4). Table 1
breaks down the potential p-value bias test over the range of
sphere weights tested. From the original Hamza et al. cohort to
the homogenized cohort under the above selected parameters, the
extreme p-value found over the spectrum of tested locations and
weights decreased by four orders of magnitude, from 4*1026 in the
original cohort, to 1*1022 in the homogenized cohort. Figure 5
shows the knocked-down individuals in the homogenization
process. Figure 6 compares estimated sphere ORs on the original
and homogenized cohorts. The comparison is performed across a
range of sphere weights.
Simulation study
Utilizing synthetic data, we compared the effect that homog-
enizing a cohort has on the GWAS typical true-positive, false-
positive and false-negative association. We still relied on the real
data Hamza et al cohort. However, the following synthetic
disease/healthy distribution was now utilized (Figure 7-a):
Diseased/healthy labels were assigned to individuals with a 0.5/
0.5 chance in the population at large, except for individuals in the
rectangular box region of Figure 7-a, where a 0.6 vs. 0.4 diseased
vs. healthy chance was used when assigning the labels. In reality,
this boxed region delimits approximately cohort individuals of
Irish or English ancestry (based on self-reported ancestry, see
Figure 2 in Valente et al. [39]). The created imbalance in the
diseased/healthy distribution is apparent in Figure 7-b. The
homogenizing algorithm was applied to this dataset (algorithm
parameters: cohort weight decrease = 9%, sphere weight = 30 and
knocked-down weight = 0.2). Figure 7-c shows the individuals
knocked-down in the homogenization process. Comparison of
Figure 7-d with Figure 7-b shows the effect of the homogenization
procedure. Next, we created a number of synthetic genotypes to
observe the effect of the homogenization procedure on the typical
false-positive and false-negative association induced by population
structure, as well as on the standard true-positive association
(Figure 7-e).
To generate typically true-positive associations (under no
population structure correction), genotype labels were assigned
to all cohort individuals as follows:
– For a diseased-phenotype individual there was a 0.57
probability of a ,A genotype assignment, while for a
healthy-phenotype individual this probability was 0.50
(yielding an OR=1.32). The process was repeated five
hundred times, thus generating five hundred such genotypes.
The red circles in Figure 7-e correspond to three such
genotypes.
– For a diseased-phenotype individual there was a 0.15
probability of a ,A genotype assignment, while for a
healthy-phenotype individual this probability was 0.10
(yielding an OR=1.59). The process was repeated five
hundred times, thus generating five hundred such genotypes.
The cyan circles in Figure 7-e correspond to three such
genotypes.
Figure 6. Estimated sphere ORs in the original and homogenized cohorts. Each subject is colored based on the estimated OR of a sphere
centered on that subject and with the sphere weight stated on the top of the respective color map (see Figure 3-a for sphere OR definition). Sphere
OR color scale reflects the symmetry of the OR definition. Note sphere OR color scale amplitude is smaller on color maps for larger sphere weights.
doi:10.1371/journal.pone.0048653.g006
Table 1. The potential p-value bias test.
Cohort
weight Sphere weight 25 50 100 200 400 800 1600
Potential p-
value bias test
3986 Original cohort 2*1024 3*1024 4*1026 4*1026 3*1024 9*1025 7*1025 4*1026
3706 Homogenized cohort 2*1022 1*1022 2*1022 2*1022 3*1022 3*1022 3*1022 1*1022
Consider the Fisher exact test p-value associated with an OR estimate for a hypothetical genotype present nowhere other than on every subject within a given spatial
sphere. Each table entry reports the smallest such p-value, over all the subject-centered spatial spheres with the stated weight. These p-values provide a comparative
measure of the potential for p-value bias due to population structure, before and after cohort homogenization. The value of the potential p-value bias test is the
smallest of these p-values across all the tested sphere weights (rightmost column). Values shown pertain to application of the test to the original and homogenized
(under the Figure 4 selected parameter values) Hamza et al. cohort. Note: for the homogenized cohort, the Fisher test is performed on the contingency table entries
rounded to the nearest integer.
doi:10.1371/journal.pone.0048653.t001
GWAS Cohort Homogenization
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Figure 7. Simulation study. a) Synthetic diseased-healthy phenotype labels were assigned to the Hamza et al. cohort subjects. b) Visualization of
the sphere ORs (at sphere weight = 500) in this synthetic dataset shows the imbalance in the diseased-healthy distribution. c) Individuals with their
statistical weight knocked-down in the cohort homogenization process (final homogenized cohort weight reduction = 9%). d) Visualization of the
sphere ORs (at sphere weight = 500), after the homogenization process. e) Synthetic genotype labels were assigned to individuals to produce the
typical true-positive, false-positive and false-negative association (under no population structure correction). The -log(p-value) for these synthetic
genotype-phenotype associations were calculated, based on four different approaches: Fisher exact test using the original cohort; Fisher exact test
using the homogenized cohort; logistic regression with the 3 PCs as covariates; and logistic regression using the homogenized cohort weights and
with the 3 PCs as covariates. f) Receiver Operating Characteristic (ROC) curves for the four different approaches. See Simulation Study Section for
details.
doi:10.1371/journal.pone.0048653.g007
GWAS Cohort Homogenization
PLOS ONE | www.plosone.org 7 October 2012 | Volume 7 | Issue 10 | e48653
– For a diseased-phenotype individual there was a 0.06
probability of a ,A genotype assignment, while for a
healthy-phenotype individual this probability was 0.03
(yielding an OR=2.06). The process was repeated five
hunderd times, thus generating five hundred such genotypes.
The green circles in Figure 7-e correspond to three such
genotypes.
The above genotypes, spanning a range of minor allele
frequencies, are homogeneously distributed across the population.
Therefore, evaluation of their association with phenotype status is
not distorted by population structure effects.
To generate typically false-positive associations (under no
population structure correction), genotypes labels were assigned
to all cohort individuals as follows:
– For an individual inside the rectangular box (Figure 7-a), there
was a 0.90 probability of a ,A genotype assignment,
regardless of phenotype status. For an individual outside the
rectangular box, there was a 0.10 probability of a ,A
genotype assignment, regardless of phenotype status. The
process was repeated five hunderd times, thus generating five
hundred such genotypes. The black crosses in Figure 7-e
correspond to four such genotypes.
– For an individual inside the rectangular box, there was a 0.80
probability of a ,A genotype assignment, regardless of
phenotype status. For an individual outside the rectangular
box, there was a 0.20 probability of a ,A genotype
assignment, regardless of phenotype status. The process was
repeated five hunderd times, thus generating five hundred
such genotypes. The blue crosses in Figure 7-e correspond to
four such genotypes.
The above genotypes have no effect on the phenotype status
(OR=1). However, the ,A genotype is highly common in the
rectangular box population, by comparison with its presence in the
population at large. In accordance with the Figure 1-b example,
the concurrent higher prevalence of both the ,A genotype and
the diseased phenotype in the rectangular box population region
generates a false apparent genotype-phenotype association.
To generate typically false-negative associations (under no
population structure correction), genotypes labels were assigned to
all cohort individuals as follows:
– For an individual below the dashed line on Figure 7-a
(PC2,22.68) and a disease phenotype, there was a 0.08
probability of a ,A genotype assignment. For an individual
below the dashed line on Figure 7-a and a healthy phenotype,
there was a 0.05 probability of a ,A genotype assignment.
For an individual above the dashed line on Figure 7-a and a
disease phenotype, there was a 0.95 probability of a ,A
genotype assignment. For an individual above the dashed line
on Figure 7-a and a healthy phenotype, there was a 0.92
probability of a ,A genotype assignment. The process was
repeated five hunderd times, thus generating five hundred
such genotypes. The magenta stars in Figure 7-e correspond
to three such genotypes. In reality, the dashed line roughly
delimits from above individuals of Irish or Italian ancestry
(based on self-reported ancestry, see Figure 2 in Valente et al.
[39]).
For the above genotypes, OR=1.65 in both the above and the
below the dashed line populations. However, the ,A genotype is
highly prevalent in the population above the dashed line, while the
A genotype is highly prevalent in the population below the dashed
line. This is enough to conceal the genotype-phenotype associa-
tion. Note that the diseased/healthy ratio is roughly identical in
the above and below the dashed line populations. As previously
illustrated by the Figure 1-c example, an homogeneous diseased/
healthy phenotype ratio across the population does not prevent
these false-negatives cases.
Figure 7-e shows -log(p-value) for some of these synthetic
genotypes, based on four different approaches:
– Original cohort: using the original cohort and the Fisher exact
test.
– Regression w/PCs: using the original cohort and logistic
regression with the first 3 PCs as covariates to account for
population structure effects.
– Homogenized: using the homogenized cohort and the Fisher
exact test.
– Homogenized + regression w/PCs: using the homogenized
cohort and logistic regression with the first 3 PCs as covariates
(the knocked-down homogenized cohort weights are em-
ployed in the logistic regression).
The true-positives, false-positives and false-negatives behave as
expected when not accounting for population structure. Both
logistic regression and the cohort homogenization method are able
to decrease -log(p-value) of the false-positives. However, the
reduction is significantly more pronounced using the cohort
homogenization method. The average -log(p-value) of true-
positives is not significantly decreased by the 9% smaller size of
the homogenized cohort. The decrease is comparable to the one
observed under logistic regression, being in this latter case
attributable to the addition of the 3 PCs as covariates. As
expected, false-negatives are not rescued by the homogenization
Figure 8. Interpreting the DZIP1 allele distribution in the
context of population structure. Based on an analysis of the
homogenized Hamza et al. cohort, a rare SNP mutation in the gene
DZIP1 that increases the susceptibility to Parkinson’s disease was found
[39]. In this cohort, individuals carrying a copy of this rare DZIP1 allele
are predominantly in a region where, as per the color maps of Figure 5,
there is still a slight relative overabundance of healthy subjects
(indicated by the blue hue in Figure 5). Thus, we conclude that the
remaining population heterogeneity in the homogenized cohort has a
propensity to diminish, rather than to inflate, the estimated OR of the
DZIP1 SNP. Above, smaller dot sizes indicate subjects with knocked-
down weight. Figure reproduced from Valente et al. [39].
doi:10.1371/journal.pone.0048653.g008
GWAS Cohort Homogenization
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method. Their -log(p-value) does significantly increased under
logistic regression. Finally, the overall best results were obtained by
combining the homogenization and logistic regression methods:
The -log(p-value) of false-positives was reduced the most, true-
positives were again only marginally affected, and false-negatives
were still rescued by the logistic regression.
Using the entire set of simulated genotypes, we built Receiver
Operating Characteristic (ROC) curves for each of the above four
approaches, showing the attainable combination of true positive
and false positive rates, depending on the selected p-value
significance level. The ROC curves confirm the observations
based on the few genotypes individually analyzed in Figure 7-e,
namely with the ROC curves being ordered from best to worst as
1) Homogenized + regression with PCs, 2) Homogenized, 3)
Regression with PCs and 4) Original cohort.
Results and Discussion
In this article we i) propose cohort homogenization as a strategy
for minimizing false-positives in a GWAS, ii) present an algorithm
for homogenizing a cohort and iii) introduce a measure for
assessing p-value bias potential due to population structure. Note
that although the homogenization method reduces false-positives,
it is not able to guarantee a given false-positive rate. When applied
to the Hamza et al. Parkinson’s cohort, the method significantly
reduced its p-value bias potential (Table 1). The intuitive character
of the approach is also advantageous. For instance, in a separate
work, this homogenized Parkinson’s cohort was analyzed under
the hypothesis-rich framework [39,40]. The main finding was a
rare SNP mutation in the gene DZIP1 that increases the
susceptibility to Parkinson’s disease. As shown in Figure 8, this
rare DZIP1 mutant occurs predominantly in a region where, as
per the color maps of Figure 6, there is still a slight relative
overabundance of healthy subjects (marked by the blue end of the
spectrum). Therefore it follows that the remaining population
heterogeneity in the homogenized cohort has a propensity to
diminish, rather than to inflate, the estimated OR of the DZIP1
SNP.
The homogenization approach introduced in this article opens a
diversity of interesting research directions for future exploration.
Firstly, the simulation work we performed highlights that the
homogenization approach could potentially be profitably used in
conjunction with other methods, namely logistic regression with
the principal components as covariates. We are currently working
on a thorough examination of such combined approaches.
Secondly, our focus on homogenizing only the diseased/healthy
marginal phenotype meant that false negatives induced by
population structure are not addressed by the approach. However,
they would be, if both phenotype and genotype marginals were
homogenized. This is computationally demanding, due to
requiring a new homogenization for every additional genotype
pair being tested. However, perhaps variations on the approach or
on the algorithm can make this full marginal matching compu-
tationally tractable and practical to apply to at least a considerable
selection of genotype pairs. Thirdly, we have not shown optimality
of the homogenization algorithm regarding the trade-off between
achieved homogenization and imposed cohort weight reduction.
Thus, the development of alternative more efficient homogeniza-
tion algorithms is another open research problem.
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